It’s exactly what Medscape Education did by launching our award-winning Hear From Her: Women in Healthcare Leadership podcast ...

The phase 3 NIAGARA trial randomised 1,063 MIBC patients to receive Imfinzi plus neoadjuvant chemotherapy prior to bladder ...

True ‘patient-centricity’ goes beyond treating disease—it means ensuring that patient voices shape research, decision-making, ...

Cuttsy+Cuttsy introduces ccura, an AI-powered healthcare communications platform that blends technology with human expertise ...

Merck & Co’s – known as MSD outside of the US and Canada – Welireg (belzutifan) has been conditionally approved by the ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been accepted for priority review by the US Food and Drug Administration (FDA ...

In the ever-evolving healthcare media landscape, Digital PR bridges the traditional benefits of reach, share of voice, and ...

The World EPA organisers have curated an exceptional programme featuring thought-provoking presentations and dynamic panel ...

The approvals were based on positive results from EV-302, in which Padcev plus Keytruda resulted in statistically significant ...

The US Food and Drug Administration (FDA) has approved Bavarian Nordic’s chikungunya vaccine Vimkunya for use in individuals ...

Bristol Myers Squibb (BMS) has shared positive five-year results from a long-term extension (LTE) study of its oral TYK2 ...

Sobi’s Sanofi-partnered efanesoctocog alfa has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA ...